Introduction 15-month-old boy was referred to our clinic for evaluation of fever and pancytopenia for 10 days. Physical examination was normal except pallor and hepatosplenomegaly (HSM). Laboratory investigation revealed hemoglobin 7.9 g/dL, leukocyte count 3.2 9 10 9 /L, absolute neutrophil count 0.6 9 10 9 /L and platelet count 35 9 10 9 /L. The peripheral blood smear demonstrated 10% atypical lymphocytes resembling virocytes; other blood cells were normal appearance. Serum lactate dehydrogenase level was 1596 U/L, triglyceride 262 mg/dL, fibrinogen 102 mg/dL, and ferritin level was 9356 ng/mL. Vitamin B12 level was very low (65 pg/mL). There was no serological evidence of infection, such as hepatitis A, hepatitis B and hepatitis C, cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus, and toxoplasmosis. The first bone marrow aspirate was hypercellular with the presence of dysmyelopoiesis, numerous histiocytes engulfing erythroid cells, neutrophils and lymphocytes leading to a suspicion of hemophagocytic lymphohistiocytosis (HLH) (Fig. 1) . No parasites were detected.
Prompt wide spectrum antibiotics, intravenous immune globulin and intramuscular vitamin B12 therapies were started, nevertheless fever and HSM were not resolved and HLH 2004 protocol was added to his treatment and evaluation of familial HLH mutations were planned. Though his clinical condition was well, his fever and laboratory finding worsened in spite of etoposide, cyclosporine and dexamethasone combinations and antibiotic modifications. Bone marrow aspiration was repeated 4th week of HLH protocol. Several amastigote form of Leishmania was demonstrated (Fig. 2) . Because the patient was not from an endemic area for leishmaniasis, no serological test was performed before second bone marrow. His fever, pancytopenia and organomegaly were resolved with liposomal amphotericin B therapy and HLH protocol was discontinued after 8 th week. Visceral leishmaniasis is a chronic and frequently lethal disease caused by protozoal parasites of the Leishmania donovani [1] . Usually manifests by fever, hepatosplenomegaly, and pancytopenia. The clinical spectrum of visceral leishmaniasis is highly variable. Several reports of HLH secondary to leishmaniasis have been published. Amastigote sequestration and chronic intracellular infection of macrophages trigger uncontrolled macrophage activation, with secretion of proinflammatory cytokines and subsequent HLH development [2] .
Previous reports have shown that the first bone marrow aspirate often fails to establish the presence of Leishmania amastigotes in 36.3% of cases and immunosuppressive therapy usually increases the number of amastigotes present on a bone marrow smear [3, 4] . Especially in endemic areas, Leishmania infection must be considered as part of the differential diagnosis in patients presenting with hemophagocytosis, and reevaluation of bone marrow and serologic tests required for accurate diagnosis. 
